Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 2000 Mar 24;66(5):1522–1530. doi: 10.1086/302901

The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma.

S Kruse 1, X Q Mao 1, A Heinzmann 1, S Blattmann 1, M H Roberts 1, S Braun 1, P S Gao 1, J Forster 1, J Kuehr 1, J M Hopkin 1, T Shirakawa 1, K A Deichmann 1
PMCID: PMC1378003  PMID: 10733466

Abstract

The platelet-activating factor (PAF) represents a phospholipid with complex biological functions, including involvement in inflammatory processes. The degrading enzyme PAF acetylhydrolase (PAFAH) represents a candidate for asthma and other atopic diseases. Two loss-of-function mutations of PAFAH are associated with severe asthma in Japanese individuals. Our aim was to look for further PAFAH variants in white populations, their possible association with atopic and asthmatic phenotypes, and their functional importance. We picked up three common variants in the PAFAH gene: Arg92His (exon 4), Ile198Thr (exon 7), and Ala379Val (exon 11). The known loss-of-function mutations were not seen. The variant allele Thr198 was found to be highly associated with total IgE concentrations in an atopic population (P=.009) and with "atopic asthma" in an asthmatic population (P=.008). The variant allele Val379 was found to be highly associated with "specific sensitization" in the atopic population (P=.002) and with "asthma" in the asthmatic population (P=.003). By use of recombinant PAFAH enzymes, the variant Val379 showed increased (14 microM) and Thr198 markedly increased (42 microM) KM values compared to the wild type (7 microM); furthermore, Vmax of Val379 was highly increased (132%). Thr198 and Val379 influence plasmatic PAFAH toward lower substrate affinities and therefore are very likely to prolong the activities of PAF. At the same time, they are associated with an increased risk to develop asthma and atopy. Thus, two PAFAH variants seem to play a key role in atopic and asthmatic processes in Caucasian populations.

Full Text

The Full Text of this article is available as a PDF (256.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adra C. N., Mao X. Q., Kawada H., Gao P. S., Korzycka B., Donate J. L., Shaldon S. R., Coull P., Dubowitz M., Enomoto T. Chromosome 11q13 and atopic asthma. Clin Genet. 1999 Jun;55(6):431–437. doi: 10.1034/j.1399-0004.1999.550606.x. [DOI] [PubMed] [Google Scholar]
  2. Averill F. J., Hubbard W. C., Proud D., Gleich G. J., Liu M. C. Platelet activation in the lung after antigen challenge in a model of allergic asthma. Am Rev Respir Dis. 1992 Mar;145(3):571–576. doi: 10.1164/ajrccm/145.3.571. [DOI] [PubMed] [Google Scholar]
  3. Bartemes K. R., McKinney S., Gleich G. J., Kita H. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J Immunol. 1999 Mar 1;162(5):2982–2989. [PubMed] [Google Scholar]
  4. Bell R., Collier D. A., Rice S. Q., Roberts G. W., MacPhee C. H., Kerwin R. W., Price J., Gloger I. S. Systematic screening of the LDL-PLA2 gene for polymorphic variants and case-control analysis in schizophrenia. Biochem Biophys Res Commun. 1997 Dec 29;241(3):630–635. doi: 10.1006/bbrc.1997.7741. [DOI] [PubMed] [Google Scholar]
  5. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet. 1999 Oct;65(4):1170–1177. doi: 10.1086/302577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clayton D., Jones H. Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet. 1999 Oct;65(4):1161–1169. doi: 10.1086/302566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gao P. S., Mao X. Q., Kawai M., Enomoto T., Sasaki S., Tanabe O., Yoshimura K., Shaldon S. R., Dake Y., Kitano H. Negative association between asthma and variants of CC16(CC10) on chromosome 11q13 in British and Japanese populations. Hum Genet. 1998 Jul;103(1):57–59. doi: 10.1007/s004390050783. [DOI] [PubMed] [Google Scholar]
  8. Hiort O., Wodtke A., Struve D., Zöllner A., Sinnecker G. H. Detection of point mutations in the androgen receptor gene using non-isotopic single strand conformation polymorphism analysis. German Collaborative Intersex Study Group. Hum Mol Genet. 1994 Jul;3(7):1163–1166. doi: 10.1093/hmg/3.7.1163. [DOI] [PubMed] [Google Scholar]
  9. Hiramoto M., Yoshida H., Imaizumi T., Yoshimizu N., Satoh K. A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke. Stroke. 1997 Dec;28(12):2417–2420. doi: 10.1161/01.str.28.12.2417. [DOI] [PubMed] [Google Scholar]
  10. Hsieh K. H., Ng C. K. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J Allergy Clin Immunol. 1993 Feb;91(2):650–657. doi: 10.1016/0091-6749(93)90271-g. [DOI] [PubMed] [Google Scholar]
  11. Kjellman N. M., Johansson S. G., Roth A. Serum IgE levels in healthy children quantified by a sandwich technique (PRIST). Clin Allergy. 1976 Jan;6(1):51–59. doi: 10.1111/j.1365-2222.1976.tb01411.x. [DOI] [PubMed] [Google Scholar]
  12. Kleine-Tebbe J., Eickholt M., Gätjen M., Brunnée T., O'Connor A., Kunkel G. Comparison between MAGIC LITE- and CAP-system: two automated specific IgE antibody assays. Clin Exp Allergy. 1992 Apr;22(4):475–484. doi: 10.1111/j.1365-2222.1992.tb00150.x. [DOI] [PubMed] [Google Scholar]
  13. Kruse S., Japha T., Tedner M., Sparholt S. H., Forster J., Kuehr J., Deichmann K. A. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology. 1999 Mar;96(3):365–371. doi: 10.1046/j.1365-2567.1999.00705.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mittal K. K. The HLA polymorphism and susceptibility to disease. Vox Sang. 1976;31?-73(3):161–173. doi: 10.1111/j.1423-0410.1976.tb02206.x. [DOI] [PubMed] [Google Scholar]
  15. Miwa M., Miyake T., Yamanaka T., Sugatani J., Suzuki Y., Sakata S., Araki Y., Matsumoto M. Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest. 1988 Dec;82(6):1983–1991. doi: 10.1172/JCI113818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ober C., Cox N. J., Abney M., Di Rienzo A., Lander E. S., Changyaleket B., Gidley H., Kurtz B., Lee J., Nance M. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet. 1998 Sep;7(9):1393–1398. doi: 10.1093/hmg/7.9.1393. [DOI] [PubMed] [Google Scholar]
  17. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  18. Prescott S. M., Zimmerman G. A., McIntyre T. M. Platelet-activating factor. J Biol Chem. 1990 Oct 15;265(29):17381–17384. [PubMed] [Google Scholar]
  19. Satoh N., Asano K., Naoki K., Fukunaga K., Iwata M., Kanazawa M., Yamaguchi K. Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma. Am J Respir Crit Care Med. 1999 Mar;159(3):974–979. doi: 10.1164/ajrccm.159.3.9807093. [DOI] [PubMed] [Google Scholar]
  20. Shirakawa I., Deichmann K. A., Izuhara I., Mao I., Adra C. N., Hopkin J. M. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today. 2000 Feb;21(2):60–64. doi: 10.1016/s0167-5699(99)01492-9. [DOI] [PubMed] [Google Scholar]
  21. Simon H. U., Tsao P. W., Siminovitch K. A., Mills G. B., Blaser K. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. J Immunol. 1994 Jul 1;153(1):364–377. [PubMed] [Google Scholar]
  22. Stafforini D. M., McIntyre T. M., Prescott S. M. Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol. 1990;187:344–357. doi: 10.1016/0076-6879(90)87041-z. [DOI] [PubMed] [Google Scholar]
  23. Stafforini D. M., Numao T., Tsodikov A., Vaitkus D., Fukuda T., Watanabe N., Fueki N., McIntyre T. M., Zimmerman G. A., Makino S. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest. 1999 Apr;103(7):989–997. doi: 10.1172/JCI5574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stafforini D. M., Satoh K., Atkinson D. L., Tjoelker L. W., Eberhardt C., Yoshida H., Imaizumi T., Takamatsu S., Zimmerman G. A., McIntyre T. M. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest. 1996 Jun 15;97(12):2784–2791. doi: 10.1172/JCI118733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stafforini D. M., Tjoelker L. W., McCormick S. P., Vaitkus D., McIntyre T. M., Gray P. W., Young S. G., Prescott S. M. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem. 1999 Mar 12;274(11):7018–7024. doi: 10.1074/jbc.274.11.7018. [DOI] [PubMed] [Google Scholar]
  26. Suzuki I., Yamaguchi E., Hizawa N., Itoh A., Kawakami Y. A new polymorphism in the 5' flanking region of the human interleukin (IL)-4 gene. Immunogenetics. 1999 Jul;49(7-8):738–739. doi: 10.1007/s002510050677. [DOI] [PubMed] [Google Scholar]
  27. Tetta C., Bussolino F., Modena V., Montrucchio G., Segoloni G., Pescarmona G., Camussi G. Release of platelet-activating factor in systemic lupus erythematosus. Int Arch Allergy Appl Immunol. 1990;91(3):244–256. doi: 10.1159/000235124. [DOI] [PubMed] [Google Scholar]
  28. Tew D. G., Southan C., Rice S. Q., Lawrence M. P., Li H., Boyd H. F., Moores K., Gloger I. S., Macphee C. H. Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins. Arterioscler Thromb Vasc Biol. 1996 Apr;16(4):591–599. doi: 10.1161/01.atv.16.4.591. [DOI] [PubMed] [Google Scholar]
  29. Tjoelker L. W., Eberhardt C., Unger J., Trong H. L., Zimmerman G. A., McIntyre T. M., Stafforini D. M., Prescott S. M., Gray P. W. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem. 1995 Oct 27;270(43):25481–25487. doi: 10.1074/jbc.270.43.25481. [DOI] [PubMed] [Google Scholar]
  30. Tjoelker L. W., Wilder C., Eberhardt C., Stafforini D. M., Dietsch G., Schimpf B., Hooper S., Le Trong H., Cousens L. S., Zimmerman G. A. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 1995 Apr 6;374(6522):549–553. doi: 10.1038/374549a0. [DOI] [PubMed] [Google Scholar]
  31. Toledano B. J., Bastien Y., Noya F., Mazer B. Characterization of B lymphocytes rescued from apoptosis by platelet-activating factor. Cell Immunol. 1999 Jan 10;191(1):60–68. doi: 10.1006/cimm.1998.1410. [DOI] [PubMed] [Google Scholar]
  32. Tsukioka K., Matsuzaki M., Nakamata M., Kayahara H. [Increased plasma levels of platelet-activating factor (PAF) and low serum PAF acetylhydrolase (PAFAH) activity in adult patients with bronchial asthma]. Arerugi. 1993 Feb;42(2):167–171. [PubMed] [Google Scholar]
  33. Wjst M., Fischer G., Immervoll T., Jung M., Saar K., Rueschendorf F., Reis A., Ulbrecht M., Gomolka M., Weiss E. H. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics. 1999 May 15;58(1):1–8. doi: 10.1006/geno.1999.5806. [DOI] [PubMed] [Google Scholar]
  34. Yamada Y., Ichihara S., Fujimura T., Yokota M. Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men. Metabolism. 1998 Feb;47(2):177–181. doi: 10.1016/s0026-0495(98)90216-5. [DOI] [PubMed] [Google Scholar]
  35. Yamada Y., Yokota M. Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281-->Arg mutation. Biochem Biophys Res Commun. 1997 Jul 30;236(3):772–775. doi: 10.1006/bbrc.1997.7047. [DOI] [PubMed] [Google Scholar]
  36. Zeger S. L., Liang K. Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986 Mar;42(1):121–130. [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES